BioTherapeutics | 1800 Kraft Dr., Suite 200, Blacksburg, VA, 24060

Publications

NLRX1 Suppresses Tumorigenesis and Attenuates Histiocytic Sarcoma through the Negative Regulation of NF-kB Signaling

Coutermarch-Ott, S., A. Simmons, V. Capria, T. LeRoith, J. E. Wilson, B. Heid, C.W. Philipson, Q. Qin, R. Hontecillas, J. Bassaganya-Riera, J.P.Y. Ting, N. Dervisis, I.C. Allen
Oncotarget 2016 Apr 1

Back to top